HCV-IN-7 is a potent, orally bioavailable pan-genotypic HCV NS5A inhibitor with picomolar activity (IC50s: 3-47 pM). It exhibits favorable pharmacokinetics and liver distribution, making it a valuable tool compound for antiviral mechanism studies and in vitro/vivo efficacy research across all major HCV genotypes.
Molekulargewicht:
768.92
CAS Nummer:
[1449756-86-8]
Formel:
C40H48N8O6S
Target-Kategorie:
HCV Protease,Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten